KLI

검색

Ulsan Univ. Repository

Browsing by 저자 : Jae-Lyun Lee

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 10건 중 1-10 번을 표시중입니다.

1 Article Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium Kosuke Takemura ; Vishal Navani ; Matthew S Ernst ; et al 2023
2 Article Clinical evidence and insights supporting the use of avelumab first-line maintenance treatment in patients with advanced urothelial carcinoma in the Asia-Pacific region Masatoshi Eto ; Jae-Lyun Lee ; Yen-Hwa Chang ; et al 2022
3 Article Clinical features and oncological outcomes of primary female urethral cancer Wonchul Lee ; Jesang Yu ; Jae-Lyun Lee ; et al 2022
4 Article Exposure-response relationship of ramucirumab in RANGE, a randomized phase III trial in advanced urothelial carcinoma refractory to platinum therapy Ronald de Wit ; Thomas Powles ; Daniel Castellano ; et al 2022
5 Article Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma Robert J Motzer ; Thomas Powles ; Michael B Atkins ; et al 2022
6 Article FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/ 3 mRNA Expression Cora N Sternberg ; Daniel P Petrylak ; Joaquim Bellmunt ; et al 2023
7 Article Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy Jeffrey Graham ; John Connor Wells ; Shaan Dudani ; et al 2022
8 Article PD-L1 Upregulation by the mTOR Pathway in VEGFR-TKI-Resistant Metastatic Clear Cell Renal Cell Carcinoma Se Un Jeong ; Hee Sang Hwang ; Ja-Min Park ; et al 2023
9 Article Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials Joaquim Bellmunt ; Ronald de Wit ; Yves Fradet ; et al 2022
10 Article RNA Sequencing Provides Evidence for Pathogenicity of a Novel CHEK2 Splice Variant (C.1009-7T>G) Rae Na ; Jinyoung Hong ; Hyunjung Gu ; et al 2022

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.